Vaso Corporation

VASO ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $35.1M $26.3M $11.3M $11.8M $6.0M $6.8M $2.1M $2.7M
Accounts Receivable — — — $22.5M $21.2M $14.0M $20.1M $15.0M
Inventory $833.0K $911.0K $1.5M $1.5M $1.1M $1.4M $1.9M $2.0M
Total Current Assets $58.6M $51.2M $45.1M $41.0M $27.8M $22.3M $24.1M $19.2M
Property, Plant & Equipment $1.3M $1.5M $1.2M $1.3M $2.2M $3.9M $5.0M $5.8M
Goodwill $11.0M $15.6M $15.6M $15.6M $15.7M $15.7M $17.3M $17.3M
Intangible Assets (Excl. Goodwill) $1.9M $1.6M $1.4M $1.5M $2.0M $3.9M $4.3M $4.7M
Total Assets $88.3M $82.9M $75.8M $71.6M $52.4M $50.4M $54.4M $50.5M
Liabilities
Accounts Payable $4.0M $4.2M $2.7M $2.3M $2.8M $6.3M $7.7M $6.3M
Total Current Liabilities $36.8M $34.7M $30.0M $31.5M $31.0M $31.7M $33.0M $35.4M
Long-Term Debt — — — $15.0K $23.0K $5.8M $8.1M $10.5M
Total Liabilities $58.9M $55.2M $48.9M $49.6M $41.3M $45.3M $50.1M $45.9M
Stockholders' Equity
Retained Earnings $-32.5M $-34.1M $-35.0M $-39.8M $-50.9M $-57.0M $-57.4M $-57.0M
Total Stockholders' Equity $29.4M $27.7M $26.8M $22.1M $11.1M $5.1M $4.3M $4.6M
← Newer Page 1 of 2 Older →